Información:
Error:
ID
21092
Descripción
Blood Sugar Response to Commercial Nutritional Supplements in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00822367
Link
https://clinicaltrials.gov/show/NCT00822367
Palabras clave
Versiones (1)
- 10/4/17 10/4/17 -
Subido en
10 de abril de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Diabetes Mellitus Type 2 NCT00822367
Eligibility Diabetes Mellitus Type 2 NCT00822367
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus Type 2 NCT00822367
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Age
Item
ages 18-75 years
boolean
C0001779 (UMLS CUI [1])
Diabetes mellitus type 2
Item
type-2 diabetes mellitus for over 3 months
boolean
C0011860 (UMLS CUI [1])
HbA1c
Item
a1c of 7.0 - 10.0% within the past 3 months
boolean
C0019018 (UMLS CUI [1])
Diabetes mellitus therapy
Item
controlled with diet /exercise and/or on oral anti-diabetic agents which are non-insulin secretatgogues, i.e. metformin and/or pioglitazone
boolean
C0948092 (UMLS CUI [1])
Informed consent
Item
able to give informed consent
boolean
C0021430 (UMLS CUI [1])
Residency
Item
expected to be in the dc metropolitan for the duration of the study
boolean
C0035182 (UMLS CUI [1])
Fasting blood glucose measurement
Item
fasting blood glucose between 70 and 250 mg/dl
boolean
C0428568 (UMLS CUI [1])
Diabetes mellitus therapy: Pharmacotherapy
Item
patients with type 2 diabetes mellitus treated with insulin secretagogues (sulfonylurea and non-sulfonylurea), pramlintide (symlin), glp-1 analogs (byetta), insulin, or alpha-glycosidase inhibitors
boolean
C0948092 (UMLS CUI [1,1])
C0013216 (UMLS CUI [1,2])
C0013216 (UMLS CUI [1,2])
HbA1c
Item
a1c under 7.0% or over 10.0%
boolean
C0019018 (UMLS CUI [1])
Fasting blood glucose measurement
Item
fasting blood glucose < 70 or > 250 mg/d
boolean
C0428568 (UMLS CUI [1])
Gastrointestinal disorders
Item
gastrointestinal disorders affecting digestion and absorption of nutrients such as lactose intolerance, chronic diarrhea, pancreatic insufficiency.
boolean
C0017178 (UMLS CUI [1])
Gastroparesis
Item
clinical history of documented gastroperesis.
boolean
C0152020 (UMLS CUI [1])
Hemodialysis or peritoneal dialysis
Item
patients on hemodialysis or peritoneal dialysis
boolean
C0019004 (UMLS CUI [1])
C0031139 (UMLS CUI [2])
C0031139 (UMLS CUI [2])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Language ability
Item
inability to read and/or speak english
boolean
C1145677 (UMLS CUI [1])